Nixon Peabody earns recognition in IAM Patent 1000 and IAM Strategy 300

July 03, 2019

Director of Media Relations
Nicholas Braude

Boston, MA. IAM, the intellectual property business media organization, has recognized Nixon Peabody’s Patent Prosecution and Litigation practice, as well as several individual attorneys, as industry leaders.

The 2019 edition of IAM Patent 1000: The World’s Leading Patent Practitioners recommends Nixon Peabody in Massachusetts for prosecution and also ranked the firm for prosecution in Illinois. The firm was recognized for its “substantial practices on both sides of the contentious/non-contentious divide” as well as its strength in technology transfer and life sciences, including, more specifically, patent work involving gene therapy and microbiomes.

Recognized as the definitive directory dedicated to identifying the world’s leading patent services providers, the IAM Patent 1000 list follows a five-month research process undertaken by a team of full-time analysts.

In addition to Nixon Peabody’s Patent Prosecution and Litigation practice, the IAM Patent 1000 notes the following attorneys as leaders in their field:

Recognized as leading lawyers for patent prosecution:

Recognized as leading lawyers for patent litigation:

Recognized as leading lawyers for transactions:

Recognized as an IP luminary:

Additionally, the IAM Strategy 300 has named two Nixon Peabody partners among the world’s leading IP strategists: Jeffrey Costellia (Washington, DC) and Seth Levy (Los Angeles). Seth is listed for licensing and technology transfer, and Jeff is recognized in the legal and IP management consultancy sectors. The IAM Strategy 300 identifies “individuals who are leading the way in the development and implementation of strategies that maximise the value of IP portfolios,” regardless of sector, according to IAM.

Back to top